Financial Ratios

ANUH PHARMA LTD.

NSE : NABSE : 506260ISIN CODE : INE489G01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE255.053.45 (+1.37 %)
PREV CLOSE ( ) 251.60
OPEN PRICE ( ) 254.00
BID PRICE (QTY) 255.10 (10)
OFFER PRICE (QTY) 256.00 (145)
VOLUME 107239
TODAY'S LOW / HIGH ( )251.85 261.00
52 WK LOW / HIGH ( ) 86265
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)7.226.105.675.719.33
   CEPS(Rs)9.168.498.684.264.99
   DPS(Rs)2.001.751.502.752.75
   Book NAV/Share(Rs)48.1442.6638.0464.7465.69
   Tax Rate(%)23.7821.8826.2425.3227.89
Margin Ratios
   Core EBITDA Margin(%)9.789.6710.257.319.30
   EBIT Margin(%)9.108.299.226.4210.24
   Pre Tax Margin(%)8.967.978.756.0310.06
   PAT Margin (%)6.836.226.464.507.25
   Cash Profit Margin (%)8.668.669.886.717.77
Performance Ratios
   ROA(%)9.638.998.635.0610.44
   ROE(%)15.9015.1116.128.7514.87
   ROCE(%)21.0519.3319.7510.8720.56
   Asset Turnover(x)1.411.441.341.121.44
   Sales/Fixed Asset(x)5.314.974.555.2013.71
   Working Capital/Sales(x)3.623.844.485.284.16
Efficiency Ratios
   Fixed Capital/Sales(x)0.190.200.220.190.07
   Receivable days105.7190.1777.8789.3282.39
   Inventory Days52.5459.9859.2359.9142.34
   Payable days125.45117.42125.15130.5583.81
Valuation Parameters
   PER(x)11.0314.0915.9110.217.25
   PCE(x)8.7010.1310.4013.6913.54
   Price/Book(x)1.652.012.371.802.06
   Yield(%)2.512.041.662.362.03
   EV/Net Sales(x)0.740.861.031.091.03
   EV/Core EBITDA(x)6.777.948.0112.179.57
   EV/EBIT(x)8.1410.2710.9916.3710.05
   EV/CE(x)0.971.201.341.021.39
   M Cap / Sales0.760.891.050.951.06
Growth Ratio
   Net Sales Growth(%)8.3912.6640.72-4.2734.68
   Core EBITDA Growth(%)9.98-5.38102.79-20.8234.87
   EBIT Growth(%)18.460.3098.80-38.1438.26
   PAT Growth(%)18.387.4798.78-38.7841.51
   EPS Growth(%)18.387.47-0.61-38.7841.51
Financial Stability Ratios
   Total Debt/Equity(x)0.000.010.070.270.03
   Current Ratio(x)1.911.981.701.372.03
   Quick Ratio(x)1.461.371.120.991.46
   Interest Cover(x)64.6125.7619.9916.2355.16
   Total Debt/Mcap(x)0.000.010.030.150.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.